Target intelligence / Profile preview

Endosomal lipid bilayer

Molecular classification
Lipid bilayer, Cellular membrane, Organelle membrane
01

Overview

The endosomal lipid bilayer is a dynamic, semi-permeable membrane that defines the boundaries of endosomes, playing a critical role in the sorting and trafficking of internalized extracellular material and surface receptors. It is composed of a complex mixture of phospholipids, cholesterol, and phosphoinositides that evolve in composition as the endosome matures from early to late stages (Nature Nanotechnology, 2021). This structure serves as a primary barrier for the intracellular delivery of macromolecular therapeutics, such as mRNA and siRNA, which must escape the endosome to reach the cytosol to be functional (Journal of Controlled Release, 2014). In many viral infections, including those caused by influenza and coronaviruses, the endosomal lipid bilayer is the site where viral envelopes fuse with host membranes, a process often triggered by the acidic environment of the endosomal lumen (Cell, 2014). Drugs targeting this structure typically aim to either facilitate endosomal escape for gene therapy or inhibit viral fusion to prevent infection (PubMed, 16115318). Additionally, alterations in the lipid composition or integrity of this bilayer are implicated in lysosomal storage disorders and neurodegenerative diseases like Alzheimer's (NIH, 2020). Understanding the biophysical properties of the endosomal lipid bilayer is essential for optimizing drug delivery systems and developing novel antiviral strategies.

Other names
Endosomal membraneEndosome membraneEndocytic membraneEndosomal vesicle membrane
02

Mechanism of action

Facilitation of endosomal escape via pH-triggered membrane destabilization or fusion; inhibition of viral-endosomal membrane fusion; modulation of endosomal pH to disrupt trafficking.

03

Biological functions

EndocytosisIntracellular traffickingMacromolecule sortingSignal transductionViral entry and uncoatingNutrient uptakeProtein degradation
04

Disease associations

Viral infectionLysosomal storage diseaseCancerNeurodegenerative diseaseMetabolic disorder
05

Safety considerations

Membrane toxicityLysosomal membrane permeabilization (LMP)Induction of apoptosisOff-target disruption of other cellular membranesInflammatory response to synthetic lipid components
06

Interacting drugs

Patisiran (Onpattro)

6 more in the full profile.

07

Biomarkers

Endosomal pHGalectin-3 (marker for membrane rupture)Rab5 (early endosome marker)Rab7 (late endosome marker)LAMP1 (lysosomal/late endosomal marker)

Beyond the preview

Go deeper on Endosomal lipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosomal lipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call